北京pk10彩票官网 www.bjn98.com “Pharma bro” Martin Shkreli isn’t letting his long stint in a New Jersey federal prison slow him down— using a contraband cellphone to tweet, publish a self-congratulatory blog, and even run his notorious, price-gouging drug company, according to a new report.
Oh, and his pals call him “A–hole.”
Shkreli continues to run his pharmaceutical company, Phoenixus AG, from his 12-person prison cell in Fort Dix, the Wall Street Journal reported Thursday.
He even used his contraband phone to dial up his hand-picked CEO recently, interrupting the exec’s safari vacation to fire him, someone familiar with the exchange told the paper.
Shkreli is using his cellphone — and prison computers — for pleasure as well as business, the paper said, the latter of which could land him in further hot water with the feds.
He flouted Twitter’s ban on his former account by creating a new one — @sriole — that doesn’t include his name, the paper said. The account has since been taken down.
He’s also keeping up a personal blog, the paper wrote, in which he compared himself to Elon Musk and quipped about the justice system.
“Memo to Roger Stone Jr.,” he posted on Jan. 25, the paper said. He then wrote, cryptically, that he hoped “a supra-judiciary entity will intervene in your case,” before adding a postscript.
“P.S. Never, ever, ever snitch.”
Shkreli is cutting his own hair with prison-issue safety scissors and has been able to maintain the same “uniform” he was seen in during numerous livestreams he had posted from his Manhattan apartment while still a free man: sweatpants and T-shirts, the paper noted.
His nickname among his new pals in lockup — who include “Krispy” and “D-Block” — is “A–hole,” one insider told the paper.
They have been watching his back, giving him protective escorts through the prison common areas and even warning him not to join the prison rock band, for which he’d hoped to play guitar, the paper said — advising him that the other band members were convicted child molesters.
More seriously, the feds are probing Shkreli’s alleged continued role at Phoenixus from behind bars, the paper said.
Phoenixus is the new name Shkreli gave to Turing Pharmaceuticals, which infamously jacked up the price of a drug used by AIDS patients from $13.50 to $750 per pill.
Shkreli is just 16 months into his seven-year sentence for securities fraud.
Related video: Martin Shkreli sentenced to 7 years in prison (provided by CBS News)
- You can buy a home building kit on AmazonDifferent sellers will send these kits to your home so you can build it yourself.Money
- Relief at the pump on the way for American drivers?Gas prices headed lower?Fox Business
- 102-year-old woman is being evicted from Southern California homeA 102-year-old woman has been told she must leave her Southern California home. Thelma Smith said she has been living in her home for 30 years. Her landlord wants her to clear out by the end of June. Amy Johnson of CBS station KCBS-TV reports from Ladera Heights, California.CBS News
Martin Shkreli sentenced to 7 years in prisonCBS News2:03
You can buy a home building kit on AmazonMoney1:07
Relief at the pump on the way for American drivers?Fox Business2:17
102-year-old woman is being evicted from Southern California homeCBS News2:13
Trump pledges $16 billion to farmers hurt by trade warUSA TODAY1:35
Disney program gives employees an opportunity to attend college for freeVeuer0:54
Boeing MAX 8 jets could be back in air by late JuneReuters1:26
Taking stock of TeslaThe Wall Street Journal.3:32
SpaceX just launched its heaviest payload everCNBC1:46
CEO's appearances in conservative media might help him land wall contractThe Washington Post1:26
University of Oklahoma gave false data to boost their rankCNN0:37
Harriet Tubman $20 bill won't happen under Trump administrationCBS News0:45
How much will your car depreciate over time?GOBankingRates1:11
Socialism no longer a dirty word on college campuses?Fox Business2:38
Netflix's Hollywood rivals are spoiling for a fightThe Wall Street Journal.4:48
How the US ban will affect Huawei technologyNext Media Animation via Reuters1:08